Effect of allogeneic HCT from unrelated donors in AML patients with intermediate-or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT
S Yamasaki, J Mori, J Kanda, N Imahashi, N Uchida… - Annals of …, 2020 - Springer
This study aimed to analyze the factors associated with outcomes of bone marrow
transplantation (UR-BMT) or cord blood stem cell transplantation from unrelated donors (UR …
transplantation (UR-BMT) or cord blood stem cell transplantation from unrelated donors (UR …
[HTML][HTML] Allogeneic Hematopoietic Cell Transplantation from Alternative Donors in Acute Myelogenous Leukemia: A Comparative Analysis
M Yanada, T Konuma, S Yamasaki, K Harada… - … and Cellular Therapy, 2021 - Elsevier
In the absence of HLA-matched related and unrelated donors, alternative donors must be
found for patients in need of allogeneic hematopoietic cell transplantation (HCT). There are …
found for patients in need of allogeneic hematopoietic cell transplantation (HCT). There are …
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged> 65 years with unfavorable cytogenetics
Unrelated donor bone marrow transplantation (UR-BMT), unrelated donor cord blood stem
cell transplantation (UR-CBT), and haploidentical peripheral blood stem cell transplantation …
cell transplantation (UR-CBT), and haploidentical peripheral blood stem cell transplantation …
Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid …
T Konuma, S Yamasaki, K Ishiyama, S Mizuno… - … and Cellular Therapy, 2024 - Elsevier
Acute myeloid leukemia (AML) is the most common indication for allogeneic hematopoietic
cell transplantation (HCT). The increased availability of alternative donor sources has …
cell transplantation (HCT). The increased availability of alternative donor sources has …
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
B Dholaria, M Labopin, J Sanz, A Ruggeri… - Journal of hematology & …, 2021 - Springer
Background Allogeneic hematopoietic cell transplantation (allo-HCT) using a mismatched
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for …
Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia
T Konuma, S Mizuno, T Kondo, Y Arai, N Uchida… - Blood Cancer …, 2022 - nature.com
Unrelated cord blood transplantation (CBT) is an alternative curative option for adult patients
with acute myeloid leukemia (AML) who need allogeneic hematopoietic cell transplantation …
with acute myeloid leukemia (AML) who need allogeneic hematopoietic cell transplantation …
Comparison of transplant outcomes between haploidentical transplantation and single cord blood transplantation in non‐remission acute myeloid leukaemia: A …
K Matsuda, T Konuma, K Fuse… - British Journal of …, 2023 - Wiley Online Library
Allogeneic haematopoietic stem cell transplantation (HSCT) is a potentially curative
treatment for some patients with acute myeloid leukaemia (AML) who are refractory to …
treatment for some patients with acute myeloid leukaemia (AML) who are refractory to …
[HTML][HTML] Comparing Single Cord Blood Transplantation and Matched Related Donor Transplantation in Non-Remission Acute Myeloid Leukemia
Y Shimomura, T Sobue, S Hirabayashi, T Kondo… - Blood, 2021 - Elsevier
Introduction Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative
treatment option for refractory and relapsed acute myeloid leukemia (R/R AML) in non …
treatment option for refractory and relapsed acute myeloid leukemia (R/R AML) in non …
The 49 th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians–Poster Session
I Yakoub-Agha - Bone Marrow Transplantation, 2023 - nature.com
Background: We previously reported inferior leukemia-free survival (LFS) following
allogeneic hematopoietic stem cell transplantation (allo-HCT) for secondary versus de novo …
allogeneic hematopoietic stem cell transplantation (allo-HCT) for secondary versus de novo …
Single cord blood transplantation versus unmanipulated haploidentical transplantation for adults with acute myeloid leukemia in complete remission
T Konuma, J Kanda, S Yamasaki, K Harada… - … and Cellular Therapy, 2021 - Elsevier
Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative post-remission
therapy for adult patients with acute myeloid leukemia (AML) in complete remission (CR) …
therapy for adult patients with acute myeloid leukemia (AML) in complete remission (CR) …